NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I believe that a two months + or - a few days before TLD is anticipated, it's doing little to move the stock price. I believe as we creep up on the release, the stock will move up in anticipation of what is to come. How high? I certainly wouldn't be surprised to see $.25, perhaps as much as $.40. How high could it go after TLD is revealed, I suspect that will be determined by what's in the TLD.

I believe the real question we should ask ourselves is, what would a proper market cap be for the company post approval of the drug. I don't believe there is a simple answer for that, as by the time it occurs more information should be available for DCVax-Direct, and that could have a lot to say about properly evaluating the company. I do however believe that most her would agree the market cap would be in the billions, the question is, how many.

It's been said that L.P. would consider a buyout for $20 billion, if we assume the share count is nearly a billion shares at that point we're talking about $20 a share. No company in it's right mind would offer more than double what a company is selling for, and most buyouts come at substantially less than double the current share price. To me that's saying that L.P.'s goal is to reach a market cap of at least $10 billion, preferably more. That's certainly a possibility after approval, though I doubt it would happen immediately, unless simultaneously DCVax-Direct results were revealed suggest it too was headed for approval, perhaps for treatment of multiple cancers.

I believe the truth is that if DCVax-Direct proves to have benefits for multiple cancers a $20 billion buyout price would be a steal. Certainly DCVax-Direct may need to be closer to approval to add greater market value to the company, but how many investors would rather wait and see than sell out without properly valuing DCVax-Direct.

Gary